BENDAMUSTINE HCL (bendamustine HCl)

25 mg/mL intravenous solution

• Dosage information is not available

bendamustine 25 mg/mL intravenous solution

• Dosage information is not available

25 mg/mL intravenous solution

• Dosage information is not available

Chronic lymphoid leukemia

• Infuse 100 mg/m2 over 30 minute(s) by intravenous route on days 1 and2 of a 28 day treatment cycle

• Infuse 25 mg/m2 over 30 minute(s) by intravenous route on days 1 and 2 of a 28 day treatment cycle

• Infuse 50 mg/m2 over 30 minute(s) by intravenous route on days 1 and 2 of a 28 day treatment cycle

• Infuse 100 mg/m2 over 10 minute(s) by intravenous route on days 1 and2 of a 28 day treatment cycle

• Infuse 25 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 28 day treatment cycle

• Infuse 50 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 28 day treatment cycle

Follicular lymphoma

• Infuse 120 mg/m2 over 60 minute(s) by intravenous route on days 1 and2 of a 21 day treatment cycle

• Infuse 90 mg/m2 over 60 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 60 mg/m2 over 60 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 120 mg/m2 over 10 minute(s) by intravenous route on days 1 and2 of a 21 day treatment cycle

• Infuse 60 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 90 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

Indolent b-cell non-hodgkin lymphoma

• Infuse 120 mg/m2 over 60 minute(s) by intravenous route on days 1 and2 of a 21 day treatment cycle

• Infuse 90 mg/m2 over 60 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 60 mg/m2 over 60 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 120 mg/m2 over 10 minute(s) by intravenous route on days 1 and2 of a 21 day treatment cycle

• Infuse 60 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 90 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

Mantle cell lymphoma

• Infuse 120 mg/m2 over 60 minute(s) by intravenous route on days 1 and2 of a 21 day treatment cycle

• Infuse 90 mg/m2 over 60 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 60 mg/m2 over 60 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 120 mg/m2 over 10 minute(s) by intravenous route on days 1 and2 of a 21 day treatment cycle

• Infuse 60 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle

• Infuse 90 mg/m2 over 10 minute(s) by intravenous route on days 1 and 2 of a 21 day treatment cycle